FDA inspection
Recipharm Monts: FDA inspection ending Oct 18, 2022
FDA inspection 1181620 · Official Action Indicated (OAI) · Monts
Key facts
| Inspection ID | 1181620 |
|---|---|
| Firm | Recipharm Monts |
| FEI number | 1000171152 |
| Address | Site de Monts Sud, 18 rue de Montbazon |
| City | Monts |
| Country | France |
| Fiscal year | 2023 |
| Inspection end date | Oct 18, 2022 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data